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Abstract In population studies, most children with episodic
viral wheeze (EVW) become symptom free by 6 years. We
studied the outcome of children with severe EVW, treated
and followed up in hospital. We followed up 78 children
<4 years, managed by paediatricians for severe EVW, to the
age of 5–10 years. We recorded respiratory symptoms,
spirometry and exhaled nitric oxide (FeNO). At follow-up,
42 children (54%) had current wheeze or dyspnoea, and 52
(67%) had current asthma. There was no significant differ-
ence between children with and without current asthma in
FEV1 (p00.420), but FeNO was higher in children with
current asthma (median (interquartile range) 14.5 (11.25–
21.50) ppb) than in those without (12.0 (10.0–13.8) ppb,
p00.020). Positive family history of asthma was the only
factor associated with current asthma (odds ratio 8.77, 95%
CI 2.88–26.69, p<0.001). This remained significant after
adjustment for duration of follow-up, gender and parental
smoking. Conclusion. Severe EVW at preschool age has a
high risk of asthma at age 5–10 years, and this is reinforced
by a positive family history of asthma and to elevated FeNO
levels.
Keywords Preschoolwheeze.Asthma.Episodicviral
wheeze.Outcome.Cohortstudies
Introduction
In population studies, one in three children under the age of
3 years have at least one episode of wheezing prior to their
third birthday, and 50% by the age of 6 years [6, 20, 21, 24].
Most preschool children with wheeze only do so during
viral upper respiratory tract infections (episodic viral
wheeze, EVW) [7]. Some young children also wheeze in
response to other triggers such as cigarette smoke, fog or
allergens (multiple trigger wheeze, MTW) [7]. In the major-
ity of these wheezy preschool children, symptoms disappear
between the ages of 3 and 6 years [24, 36]. Disappearance of
wheeze over time is more likely in preschool children with a
low level of lung function in infancy [24, 36], with maternal
smoking [1, 24] and in children with EVW [9, 16].
The common perception that EVW has a high likelihood
of spontaneous resolution over time is based on general
population studies which examined the outcome of wheeze
in children who had at least one episode of (usually mild)
wheezing [7]. Preschool children with more frequent or
more severe episodes of wheezing are more likely to devel-
op asthma than children with mild or isolated episodes of
wheeze in early life [4, 9, 10, 23]. Clinical studies on the
outcome of more severe wheeze in early childhood are rare,
however. Only a few studies have investigated the long-term
prognosis of preschool children hospitalised for a severe
episode of wheezing [17, 37]. To our knowledge, no
follow-up studies of clinical cohorts of preschool children
with EVW have been performed to date.
We hypothesised that preschool children with EVW, re-
ferred to a hospital setting for management of their
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would therefore be at higher risk of wheeze persisting beyond
the preschool years thanchildrenwithviral associatedwheeze
in population studies.
Methods
Study population and participant recruitment
We performed a retrospective chart review of all children
who had been treated and follow-up at the Princess Amalia
Children's Clinic between 2002 and 2007 for symptoms of
recurrent wheeze and who were <4 years of age at time of
their first visit to the clinic. In the Netherlands, children can
only be seen by a paediatrician after referral by their general
practitioner; Dutch guidelines for management of asthma/
wheeze in primary care recommend referral to a paediatrician
in case of severe or therapy-resistant signs and symptoms [5].
The hospital chart contained a standardised asthma/
wheeze history questionnaire, in which the pattern of
wheeze was evaluated by asking the parents “Does your
child's wheeze/dyspnoea only occur during viral colds?”
and “Does your child ever wheeze when (s)he is not having
a viral cold?” In order to identify children with EVW [7], we
included only patients with an affirmative answer to the
former and a negative answer to the latter question in the
hospital chart. Patients in whom the answer to either of these
questions was missing or unclear were excluded. Thus, our
population consisted of children with exclusive EVW, who
were referred by their general practitioner because of severe
or therapy-resistant symptoms (from here on referred to as
“severe EVW”). Clinical management in these patients,
including the decision to test for allergic sensitization (by
Phadiatop screening test for atopy) [38] and treatment with
anti-inflammatory maintenance medication, was at the dis-
cretion of the attending paediatrician.
Data on wheezing history, personal history of eczema,
family history of asthma and eczema, parental smoking
habits and results of tests of atopic sensitization (if per-
formed) were obtained from the hospital chart from the time
period when the child was under follow-up at our clinic. In
2009, all children with severe EVW identified in this way
were invited by letter and telephone to return to the clinic for
a follow-up assessment. Written parental informed consent
was obtained, and the study was approved by the hospital
Ethics Review Board, a certified subsidiary of the national
committee of medical ethics in the Netherlands.
Measurements at follow-up in 2009
Questionnaire Respiratory symptoms were recorded by
ISAAC questionnaire for children of 6–7y e a r s[ 2]. In
addition, parents were asked whether their child had used
any oral or inhaled medication for respiratory symptoms or
asthma during the previous 12 months and whether a doctor
had diagnosed asthma in their child after the age of 4 years.
Lung function A complete expiratory flow-volume curve
was obtained on the Jaeger MasterScreen (Jaeger, Houston,
TX, USA) at our pulmonary function laboratory according
to ERS/ATS guidelines [26]. Measurements were supervised
by skilled technicians encouraging the children to perform
optimal measurements. We recorded forced expiratory vol-
ume in 1 s (FEV1) and the ratio of FEV1 to forced vital
capacity (FEV1/FVC) and expressed obtained values as
percent of predicted [34].
Exhaled nitric oxide The fractional concentration of exhaled
nitricoxide(FeNO)wasmeasuredbyNIOXMINO(Aerocrine,
Solna, Sweden) and expressed in parts per billion [35].
Definitions
Current wheeze at follow-up was defined as an affirmative
answer to the question “has your child wheezed during the
last 12 months?”; current dyspnoea as an affirmative answer
to the corresponding question on dyspnoea/shortness of
breath during the last 12 months. Children were classified
as current asthma medication users when their parents
reported use of inhaled bronchodilators, inhaled corticoste-
roids, oral montelukast or oral corticosteroids in the last
year. Current asthma was defined as current wheezing,
current dyspnoea or current asthma medication use.
Statistical analyses
Statistical analyses were performed using chi-squared tests
to compare proportions and by Mann–Whitney U test to
compare medians and distributions between groups. Non-
parametric testing was used throughout because of small
group sizes and skewed distributions. Multiple logistic re-
gression analysis was carried out to identify patient charac-
teristics associated with the presence or absence of current
asthma at follow-up at the age of 5–10 years. All analyses
were performed with SPSS 16.0. p values<0.05 were con-
sidered statistically significant.
Results
Subjects
Between 2002 and 2007, 483 children <4 years were diag-
nosed, treated and followed up at our clinic for recurrent
948 Eur J Pediatr (2012) 171:947–954severe wheeze. In the majority of cases, medical history data
recorded in the hospital chart were insufficient to allow
reliable classification as MTW or EVW (Fig. 1). Because
we were specifically interested in children with EVW, we
only included the 134 children in whom this pattern of
wheeze could be reliably identified from data in the hospital
chart (27.8% of the 483 children whose charts were
reviewed). There were no significant differences in age,
gender and rate of hospitalisation for wheeze between the
134 children with EVWand the children who were excluded
because of insufficient chart data or those with MTW (all p
values>0.4) (Fig. 1).
After excluding patients whose parents could not be
contacted or refused participation, a total of 78 patients
completed the study (58.2% of the 134 children with
EVW (Fig. 1)) at the age of 5–7 years in 2009; their
characteristics are presented in Table 1. There were no
significant differences in clinical and demographic charac-
teristics between our study population and non-participants,
indicating that our study population was representative of
the root population of 134 EVW patients.
Twenty-four patients had been admitted to hospital at least
once before the age of 4 years because of severe wheeze. The
median number of wheezing episodes in these patients in the
year before referral to our clinic was 6 (interquartile range
(IQR) 3 to 8).
Symptoms and medication use at follow-up
The median duration of time between the last visit to the
clinic for preschool wheeze, or the fourth birthday of the
patient (whichever was last), and the follow-up visit in 2009
was 3.90 (IQR 2.30–4.80) years. At follow-up at the age of
5–10 years, 31 children had current wheeze, 34 had current
dyspnoea and 42 had either (Fig. 2). Of these 42 children
with current wheeze or dyspnoea, 23 (54.8%) only had such
symptoms during viral colds (EVW), and 19 also had symp-
toms after exposure to other stimuli (MTW). In the MTW
group, viral colds were also the most important trigger; a
total of 37/42 children with current wheeze or dyspnoea at
follow-up had these symptoms during viral colds. MTW
was more likely in children with a positive family history
of asthma (17/52) than in those without (2/20), although the
difference did not quite reach statistical significance (p0
0.08). Personal and family history of eczema, hospital ad-
mission for wheeze at young age, atopic sensitization at
young age and parental smoking were not related to MTW
at the age of 5–10 years (p>0.4).
Current asthma medication use was reported in 45 chil-
dren, 9 of whom (20%) only used inhaled bronchodilators
on demand; the remaining 36 were using inhaled cortico-
steroids as daily controller therapy. There were no children
using montelukast. Ten of these 45 current asthma medica-
tion users (22.2%) had been free from dyspnoea or wheeze
in the year before completion of the questionnaire (Fig. 2).
Of the 52 children with current asthma symptoms or current
asthma medication use, 48 (92.3%) had a doctor's diagnosis
of asthma made or confirmed after the age of 4 years.
Lung function and exhaled nitric oxide at follow-up
Complete flow-volume curves were obtained in 75 children
(96.2%) and successful FeNO measurements in 60 (76.9%).
Results are presented in Table 2. There were no significant
differences in spirometry values between children with and
without current asthma, but FeNO was significantly higher
Fig. 1 Patient disposition
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(n020) (p00.020, Table 2). When comparing children with
and without current dyspnoea or wheeze, FVC (p00.20),
FEV1 (p00.75) and FeNO (p00.11) were not significantly
different, but FEV1/FVC ratio was significantly lower in
children with current wheeze or dyspnoea (median 85.2%,
IQR 81.9–88.6%) than in those without (median 87.8%,
IQR 81.9–91.5%, p00.011). There were no significant dif-
ferences in spirometry or FeNO values between children
with EVW (n02 3 )o rM T W( n019) at follow-up (all p
values>0.30).
Differences between children with and without current
asthma at follow-up
A comparison of clinical and demographic characteristics
between children with and without current asthma at follow-
up is presented in Table 3. A positive family history was the
only risk factor significantly associated with current asthma
at age 5–10 years (odds ratio (OR) 8.77, 95% CI 2.88–
26.69, p<0.01). This association between family history of
asthma in preschool children with EVW and the risk of
current asthma at the age of 5–10 years in these patients at
Table 1 Characteristics of study population and excluded patients
Study population
(n078)
Excluded patients
(n056)
p value
a
Median age in years at initial presentation to secondary care (interquartile range) 1.85 (1.28–3.05) 1.90 (1.30–3.10) 0.85
Male gender number (%) 54 (69.2) 34 (60.7) 0.31
Family history of asthma number (%) 36 (64.2) 30 (53.4) 0.72
Personal history of eczema number (%) 22 (28.2) 13 (23.2) 0.42
Allergic sensitization number (%)
b 14 (33.3) 10 (34.5) 0.92
Parents smoking in the house number (%) 12 (15.4) 11 (19.6) 0.52
Ever hospitalized for asthma/wheeze number (%) 23 (31.1) 18 (32.1) 0.74
Data obtained from retrospective review of hospital chart when the child was first referred to secondary care (before the age of 4 years) and
followed up for severe episodic viral wheeze
aMann–Whitney U test for comparison of age; chi-squared tests for all other comparisons
bOnly tested in 42 patients in study population and in 29 excluded patients
Fig. 2 Presence of current
wheeze, dyspnoea, or asthma
medication use at the age of 5–
10 years in 78 children who had
been referred to a hospital-
based paediatric asthma clinic
for severe EVW when they
were 4 years of age or younger
950 Eur J Pediatr (2012) 171:947–954follow-up remained significant after adjustment for age,
gender and the duration of time between initial management
of EVW during preschool age and the follow-up visit in
2009 (adjusted OR 9.30, 95% CI 2.68–32.13, p<0.01).
Discussion
In contrast to population studies, in which the large majority
of preschool children with EVW become symptom free
between the ages of 3 and 6 years [9, 24, 36], we found that
two thirds of preschool children with severe EVW referred
to a hospital-based paediatric asthma clinic had current
asthma at the age of 5–10 years (Fig. 2). Children with
current asthma at age 5–10 years had elevated FeNO levels
(Table 2). The only risk factor significantly associated to
current asthma at the age of 5–10 years in these preschool
children with EVW was a positive family history of asthma
(Table 3), independent of age, gender and duration of
follow-up. Our results suggest that EVW, when severe
enough to warrant referral to secondary care, is not an
innocuous disease which may be expected to disappear once
children reach primary school age but carries a high likeli-
hood of developing into bronchial asthma.
To our knowledge, ours is the first study to follow up a
hospital-based cohort of preschool children with EVW to
the age when the presence of asthma can be reliably
assessed. Until now, all data on the risk of persistence of
wheeze in preschool children has come from population
studies. Although such studies may be useful and informa-
tive to unravel the different clinical phenotypes of preschool
wheezing and their outcome at population level, these data
cannot be used to predict the outcome of children with more
severe recurrent wheeze managed and followed up in sec-
ondary or tertiary care. Our results are in line with results
from two Scandinavian cohorts of young children (<2 years
of age) admitted to hospital for severe wheezing, where 40–
49% of patients had asthma at the age of 5–7 years [17, 37].
Further follow-up showed that the high risk of asthma
persisted into adulthood [15]. Taken together, these data
may be used in paediatric hospitals and departments to
counsel parents of preschool children with EVW on the
expected outcome of wheeze in these patients.
The factors associated with current asthma in our study
(positive family history of asthma and elevated FeNO levels
at age 5–10 years) are in accordance with results from
population studies on the outcome of preschool wheeze [1,
9, 11, 24]. Although there was a clear trend for atopic
sensitization at preschool age to be more common in chil-
dren with current asthma at follow-up, the low number of
patients tested for atopic sensitization in our study reduced
the power to demonstrate the statistical significance of this
difference (Table 3). Children seen in a hospital setting with
severe EVW and a positive family history of asthma or
evidence of atopy may therefore be considered at high risk
of asthma at 5–10 years of age.
Almost half of the preschool children with EVW whose
symptoms persisted to or recurred before the age of 5–
Table 2 Lung function and ex-
haled nitric oxide values in chil-
dren with and without current
asthma (current dyspnea,
wheeze or asthma medication
use) at follow-up
IQR interquartile range
aMann–Whitney U test
Current asthma (n051) No current asthma (n024) p value
a
Median IQR Median IQR
FEV1 % predictive 104.0 97.0–114.0 106.5 91.0–111.0 0.420
FVC % predictive 106.0 95.0–114.0 103.5 96.5–107.0 0.189
FEV1/FVC (%) 85.2 81.8–89.0 88.0 83.7–92.4 0.101
FeNO (ppb) 14.5 11.25–21.50 12.0 10.0–13.8 0.020
Table 3 Demographic and clin-
ical characteristics of children
with and without current asthma
at follow-up
IQR interquartile range
aMann–Whitney U test for age
and duration comparisons;
chi-squared tests for all other
comparisons
Current asthma
(n052)
No current asthma
(n026)
p
value
a
Median age in years at follow-up (IQR) 6.72 (6.24–8.00) 6.88 (5.94–7.99) 0.73
Median duration in years of follow-up
(IQR)
3.80 (3.24–4.67) 3.97 (3.43–4.85) 0.76
Male gender number (%) 31 (59.6%) 20 (76.9%) 0.13
Family history of asthma number (%) 45 (86.5%) 11 (42.3%) <0.01
Personal history of eczema number (%) 26 (50%) 15 (57.7%) 0.51
Allergic sensitization number (%) 13/34 tested (38.2%) 1/8 tested (12.5%) 0.17
Parents smoking in the house number (%) 6 (11.5%) 6 (23.1%) 0.18
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age but also responded to other triggers (Fig. 2). This con-
firms earlier observations that EVW may develop over time
into MTW and vice versa [30]. Although there was a trend
for family history of asthma to be associated with MTW, our
study was underpowered to identify risk factors for MTW.
In the other half of EVW preschool children, the pattern of
wheezing only during viral colds persisted into school age.
This is in agreement with earlier studies showing that EVW
is not confined to the preschool age range but may also be
observed in school-aged children and adults [13, 25].
The relationship of lung function and FeNO at school age
to wheezing disorders in preschool children is unclear. In the
Tucson study, both reduced lung function during infancy
and EVW were associated with wheeze resolving before the
sixth birthday [9, 24]. Because lung function tends to track
throughout childhood [31], children with EVW may there-
fore be expected to have reduced lung function at school
age. However, no clear relationship between lung function
and preschool wheezing phenotypes were observed in other
birth cohort studies [19, 21]. Similarly, EVW in preschool
children has been associated with elevated, normal and
reduced FeNO levels in different studies [8, 11, 12, 28].
This suggests that EVW may not be a well-defined clinical
entity and may comprise different inflammatory and func-
tional phenotypes [29]. The normal level of lung function in
the children with current asthma in our study is in accor-
dance with a range of previous studies [3, 27, 33]. The
elevated FeNO levels in the patients with current asthma
supports the notion that these children did indeed have
atopic asthma and were not overdiagnosed or incorrectly
treated as such because of nonspecific respiratory
symptoms.
We acknowledge the following limitations of our study.
First, our study sample was relatively small, limiting our
ability to identify risk factors for asthma at the age of 5–
10 years. We deliberately chose to be very strict in including
only children with exclusive EVWand to exclude patients in
whom the hospital chart records either suggested MTW or
were insufficient to confirm that wheeze only occurred
during viral colds. Sadly, many hospital chart records
contained missing data on the pattern of wheeze in early
childhood (Fig. 1). Our study population was representative
of the root population of 134 children positively identified
as having EVW (Table 1) and of the original population
seen in our hospital in terms of age and gender. Other
studies in larger prospective hospital-based cohorts of
EVW patients are needed to confirm our results.
A second disadvantage is that we had no data to confirm
the presence of respiratory viruses in the airways during
episodes of wheezing in early childhood. Studies that did
look at respiratory viruses in preschool wheeze have sug-
gested that rhinovirus and respiratory syncytial virus may be
of particular importance in increasing the likelihood of
persistent asthma [14, 16, 18, 22, 32]. Most clinicians,
however, refrain from testing for respiratory viruses in
wheezy preschool children, and viral testing is not recom-
mended in clinical guidelines for preschool wheeze [7].
Thus, our results reflect current clinical practice in which
the pattern of wheeze in early childhood (EVW versus
MTW) is only assessed through parental history.
Thirdly, the duration of follow-up was variable in our
study, ranging from 3.7 to 8.8 years. Given the favourable
natural history of EVW in population studies [9, 24], we
considered the possibility that children with a longer time
period between initial symptoms at preschool age and
follow-up at the age of 5–10 years would be more likely
to have outgrown their symptoms. This, however, was not
the case (Table 3), and the relationship of positive family
history of asthma to current asthma at the age of 5–10 years
remained significant after adjustment for the duration of
follow-up.
A final limitation is that our study was performed in a
single centre, which may limit the generalizability of our
findings. Because our paediatric asthma clinic is situated in
the only district general hospital in a catchment area of
400,000 inhabitants, we believe that our study sample is
representative of the preschool children with EVW in sec-
ondary care.
Inconclusion,ourstudyshowsthatpreschoolchildrenwith
EVW, who have been referred to a hospital-based paediatric
asthmaclinic because ofsevere symptoms, have a highrisk of
persistent asthma at the age of 5–10 years. This is in agree-
ment with earlier follow-up studies of preschool children
admitted to hospital for severe virus-associated wheeze. Epi-
sodic viral wheeze in preschool children should therefore not
be regarded as a transient and innocuous disease, in particular
when symptoms are severe enough to warrant referral to
secondary care. We recommend to evaluate, manage and
follow up preschool children with severe EVW as seriously
as one would in school-aged children with asthma.
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